Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

793 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Activation of protein phosphatase causes alternative splicing of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): potential effect on immune surveillance.
Kamachi M, Aramaki T, Tanimura S, Ichinose K, Fujikawa K, Iwamoto N, Yoshizaki A, Ida H, Kawakami A, Kohno M, Eguchi K. Kamachi M, et al. Among authors: fujikawa k. Biochem Biophys Res Commun. 2007 Aug 17;360(1):280-5. doi: 10.1016/j.bbrc.2007.06.046. Epub 2007 Jun 15. Biochem Biophys Res Commun. 2007. PMID: 17583676
Different expression levels of TNF receptors on the rheumatoid synovial macrophages derived from surgery and a synovectomy as detected by a new flow cytometric analysis.
Ida H, Aramaki T, Nakamura H, Fujikawa K, Arima K, Tamai M, Kamachi M, Satoh K, Origuchi T, Kawakami A, Furuichi I, Kawabe Y, Eguchi K. Ida H, et al. Among authors: fujikawa k. Cytotechnology. 2009 Jul;60(1-3):161-4. doi: 10.1007/s10616-009-9229-5. Epub 2009 Sep 26. Cytotechnology. 2009. PMID: 19784790 Free PMC article.
Proinflammatory cytokines synergistically enhance the production of chemokine ligand 20 (CCL20) from rheumatoid fibroblast-like synovial cells in vitro and serum CCL20 is reduced in vivo by biologic disease-modifying antirheumatic drugs.
Kawashiri SY, Kawakami A, Iwamoto N, Fujikawa K, Aramaki T, Tamai M, Arima K, Kamachi M, Yamasaki S, Nakamura H, Tsurumoto T, Kono M, Shindo H, Ida H, Origuchi T, Eguchi K. Kawashiri SY, et al. Among authors: fujikawa k. J Rheumatol. 2009 Nov;36(11):2397-402. doi: 10.3899/jrheum.090132. Epub 2009 Oct 1. J Rheumatol. 2009. PMID: 19797510
Switching to the anti-interleukin-6 receptor antibody tocilizumab in rheumatoid arthritis patients refractory to antitumor necrosis factor biologics.
Kawashiri SY, Kawakami A, Iwamoto N, Fujikawa K, Aramaki T, Tamai M, Arima K, Ichinose K, Kamachi M, Yamasaki S, Nakamura H, Origuchi T, Ida H, Eguchi K. Kawashiri SY, et al. Among authors: fujikawa k. Mod Rheumatol. 2010 Feb;20(1):40-5. doi: 10.1007/s10165-009-0235-4. Epub 2009 Oct 3. Mod Rheumatol. 2010. PMID: 19802651
Cutaneous vasculitis induced by TNF inhibitors: a report of three cases.
Fujikawa K, Kawakami A, Hayashi T, Iwamoto N, Kawashiri SY, Aramaki T, Ichinose K, Tamai M, Arima K, Kamachi M, Yamasaki S, Nakamura H, Ida H, Origuchi T, Eguchi K. Fujikawa K, et al. Mod Rheumatol. 2010 Feb;20(1):86-9. doi: 10.1007/s10165-009-0232-7. Epub 2009 Oct 8. Mod Rheumatol. 2010. PMID: 19812889
Examination of IgM rheumatoid factor (IgM-RF) and anti-cyclic citrullinated peptide antibody (anti-CCP Ab) in Japanese patients with palindromic rheumatism.
Tamai M, Kawakami A, Iwanaga N, Fujikawa K, Tanaka F, Aramaki T, Izumi Y, Aratake K, Arima K, Kamachi M, Nakamura H, Huang M, Ida H, Origuchi T, Eguchi K. Tamai M, et al. Among authors: fujikawa k. Intern Med. 2006;45(12):795-7. doi: 10.2169/internalmedicine.45.1407. Epub 2006 Jul 18. Intern Med. 2006. PMID: 16847371 Free article.
793 results